The main excitatory inputs to the striatum arising from the cortex and the thalamus innervate both striatal spiny projection neurons and interneurons. These glutamatergic inputs to striatal GABAergic interneurons have been suggested to regulate the spike timing of striatal projection neurons via feedforward inhibition. Understanding how different excitatory inputs are integrated within the striatal circuitry and how they regulate striatal output is crucial for understanding basal ganglia function and related behaviors. Here, using VGLUT2 mice from both sexes, we report the existence of a glutamatergic projection from the mesencephalic locomotor region to the striatum that avoids the spiny neurons and selectively innervates interneurons. Specifically, optogenetic activation of glutamatergic axons from the pedunculopontine nucleus induced monosynaptic excitation in most recorded striatal cholinergic interneurons and GABAergic fastspiking interneurons. Optogenetic stimulation in awake head-fixed mice consistently induced an increase in the firing rate of putative cholinergic interneurons and fast-spiking interneurons. In contrast, this stimulation did not induce excitatory responses in spiny neurons but rather disynaptic inhibitory responses ex vivo and a decrease in their firing rate in vivo, suggesting a feedforward mechanism mediating the inhibition of spiny projection neurons through the selective activation of striatal interneurons. Furthermore, unilateral stimulation of pedunculopontine nucleus glutamatergic axons in the striatum induced ipsilateral head rotations consistent with the inhibition of striatal output neurons. Our results demonstrate the existence of a unique interneuron-specific midbrain glutamatergic input to the striatum that exclusively recruits feedforward inhibition mechanisms.
Introduction
The striatum constitutes the main input structure of the basal ganglia. Its core physiological function is the integration of ex-trinsic inputs and their transmission to downstream basal ganglia structures. Cortex and thalamus comprise two of its major excitatory inputs (Kemp and Powell, 1971; Albin et al., 1989; DeLong, 1990; Silberberg and Bolam, 2015) , innervating both spiny projection neurons (SPNs) and interneurons. Most striatal GABAergic interneurons inhibit SPNs monosynaptically (Koó s and Tepper, 1999; Gittis et al., 2010; Ibáñez-Sandoval et al., 2010 Szydlowski et al., 2013; Straub et al., 2016 ; but see , and cholinergic interneurons (CINs) disynaptically through nicotinic activation of striatal GABAergic interneurons (English et al., 2011; Faust et al., 2016) , thus suggesting that striatal interneurons are in a position to modulate the activity of SPNs through feedforward inhibition. Notably, glutamatergic afferents make stronger connections onto interneurons than principal cells in many regions, supporting the idea that interneurons can acutely shape network activity through feedforward inhibitory mechanisms (Parthasarathy and Graybiel, 1997; Ramanathan et al., 2002; Gabernet et al., 2005; Mallet et al., 2005; Cruikshank et al., 2007; Isaacson and Scanziani, 2011) . So far, the most studied form of feedforward inhibition in striatum is through cortical activation of fast-spiking interneurons (FSIs) (Koó s and Tepper, 1999; Mallet et al., 2005; Martiros et al., 2018; Owen et al., 2018) ; but given the prominent excitatory innervation originating in the thalamus and other subcortical structures (Kemp and Powell, 1971; Albin et al., 1989; DeLong, 1990; Pan et al., 2010; Wall et al., 2013; Silberberg and Bolam, 2015; Klug et al., 2018) , it is likely that they also contribute to shaping the activity of striatal interneurons (Assous and Tepper, 2019) and, consequently, driving feedforward inhibition. Understanding how different excitatory inputs are integrated within striatal circuitry and how they regulate striatal output is crucial for understanding basal ganglia-related function and behavior.
We recently described a novel pathway that originates in the pedunculopontine nucleus (PPN) and whose activation modulates the activity of striatal circuits by increasing the discharge of cholinergic interneurons and inhibiting the activity of SPNs (Dautan et al., 2018) . While these effects were associated with cholinergic neurons of the PPN, retrograde tracing studies revealed that a large proportion of striatal-projecting neurons in the PPN were noncholinergic (Dautan et al., 2014) . Glutamatergic neurons constitute the largest neuronal population in the PPN (Wang and Morales, 2009 ) and innervate different components of the basal ganglia, including midbrain dopaminergic neurons (Ros et al., 2010; Galtieri et al., 2017) and the striatum (Klug et al., 2018) . Furthermore, PPN glutamatergic neurons have recently been implicated in the regulation of motor activity as a downstream target of the basal ganglia (Roseberry et al., 2016; Caggiano et al., 2018) , suggesting that their bidirectional connectivity with basal ganglia nuclei may underlie their role in motor behavior.
Using a combination of anatomical and electrophysiological approaches, here we report the existence of a glutamatergic projection to the striatum originating in the PPN that selectively innervates interneurons and produces feedforward inhibition of SPNs. Activation of this pathway induces ipsiversive head movements. Our results thus demonstrate the existence of a midbrain excitatory projection whose activation modulates striatal network activity strictly through feedforward inhibition of SPNs.
Materials and Methods
All procedures used in this study were performed in agreement with the National Institutes of Health Guide to the care and use of laboratory animals and with the approval of the Rutgers University Institutional Animal Care and Use Committee (Newark). Male and female WT and VGLUT2-Cre (hemizygotic; The Jackson Laboratory, #016963) mice were bred, housed in groups of up to 4 per cage, and maintained on a 12 h light cycle (7:00 A.M. to 7:00 PM) with ad libitum access to food and water. All experiments used mice of both sexes.
Tracing experiments. Adult male and female WT and VGLUT2-Cre weighting between 15 and 20 g were anesthetized with isoflurane (1.5%-2.5%, delivered with O 2 , 1 ml/min) and placed in a stereotaxic frame. Bupivacaine was used as a local anesthetic at the site of the incision. Animals were then injected with an AAVr-CAG-Td-tomato (200 nl; gift from the Janelia Research Institute and the laboratory of Dr. J. Dudman) or Fluorogold (400 nl, 2% in saline for WT mice; Fluorochrome) or AAVr-Flex-TdTomato (400 nl; Addgene, #28306) in the dorsal striatum (2 ϫ 200 nl in the dorsomedial and the dorsolateral striatum; anteroposterior 1.0 mm; mediolateral 2.0 mm; dorsoventral 3.5/3.0/2.5 mm from dura) to visualize retrogradely labeled neurons. To analyze the topography of the striatal projections, we injected AAV-Flex-YFP (50 nl, University of North Carolina Vector Core) or AAV-DIO-GFP-2A-mRuby-synaptophysin (Virus Core, Stanford University). Following 2 weeks of recovery, animals were transcardially perfused and the brain tissue processed for immunocytochemistry. For all experiments, animals where the injection site was not constrained to dorsal striatum were discarded from further analyses.
Immunocytochemistry and immunofluorescence. Following behavioral, electrophysiological, or anatomical experiments, mice were anesthetized with an overdose of pentobarbital (200 mg/kg, i.p.) and then transcardially perfused with 0.05 M PBS followed by ice-cold 4% PFA in PBS (50 ml). Brains were prepared for either coronal or parasagittal sections (50 m) in PBS using a vibratome (VT1200S, Leica Microsystems). For ex vivo experiments, following recording, slices containing the biocytinfilled neurons were transferred to a 4% PFA solution for 48 h before being processed. Slices were then transferred to a blocking solution (10% normal donkey serum in 1% Triton X-100 in PBS) for 1 h. Sections were then washed and incubated overnight with an antibody against ChAT (Abcam, AB144P, made in goat, 1/500), parvalbumin (Synaptic Systems, 195004 , made in guinea pig, 1/500) or GFP (Invitrogen, A21311, made in rabbit, 1/1000). Following several washes, sections were incubated for 4 h in CY5-conjugated donkey antibody (anti-goat, Jackson ImmunoResearch Laboratories, 705-175-147, 1/1000) and Alexa-488-conjugated donkey antibody (anti-rabbit, Jackson ImmunoResearch Laboratories, 711-545-152, 1/1000). All sections were also processed for biocytin using a CY3-congugated streptavidin solution in PBS containing 0.03% Triton. Sections resulting from tracer injections, in vivo electrophysiology, and behavioral experiments were processed with antibodies against GFP (as above) or mCherry (anti-rabbit, Abcam, AB167453, made in rabbit, 1/1000). High-resolution images were captured using a confocal microscope (Olympus Fluoview FV1200). Images were analyzed using ImageJ software.
Ex vivo brain slice recordings. VGLUT2-Cre mice were injected with AAV-Flex-ChR2-GFP (200 nl, University of North Carolina Vector Core) in the PPN (anteroposterior Ϫ4.5, mediolateral 1.25, dorsoventral 3.3 mm). Approximately 6 weeks after virus injection, mice were deeply anesthetized with an intraperitoneal injection of 80 mg/kg ketamine/20 mg/kg xylazine, and perfused transcardially with an ice-cold N-methyl D-glucamine (NMDG)-based solution containing the following (in mM): 103.0 NMDG, 2.5 KCl, 1.2 NaH 2 PO 4 , 30.0 NaHCO 3 , 20.0 HEPES, 10.0 glucose, 101.0 HCl, 10.0 MgSO 4 , 2.0 thiourea, 3.0 sodium pyruvate, 12.0 N-acetyl cysteine, 0.5 CaCl 2 (saturated with 95% O 2 and 5% CO 2 , pH 7.2-7.4). After decapitation, the brain was quickly removed into a beaker containing ice-cold oxygenated NMDG-based solution before slicing. Oblique parahorizontal sections, 300 m in thickness, were cut in the same medium using a Vibratome 3000. Sections were immediately transferred to an oxygenated NMDG-based solution at 35°C for 5 min, after which they were transferred to oxygenated normal Ringer's solution at 25°C until used.
The recording chamber was constantly perfused (2-4 ml/min) with oxygenated Ringer's solution at 32°C-34°C. Drugs were applied in the perfusion medium and were dissolved freshly each day in Ringer's solution. Slices were initially visualized under epifluorescence illumination with a digital frame transfer camera (Cooke SensiCam) mounted on an Olympus BX50-WI epifluorescence microscope with a 40ϫ long working distance water-immersion lens to visualize the transduction field in the striatum. Visualization was then switched to infrared-differential interference contrast microscopy for the actual patching of the neuron.
Micropipettes for whole-cell recording were constructed from 1.2 mm outer diameter borosilicate pipettes on a Narishige PP-83 vertical puller. The standard internal solution for whole-cell current-clamp recording was as follows (in mM): 130 K-gluconate, 10 KCl, 2 MgCl 2 , 10 HEPES, 4 Na 2 ATP, 0.4 Na 2 GTP, pH 7.3. Biocytin (0.2%, Sigma-Aldrich) was also added to the internal solution to allow description of the neuronal morphology of recorded neurons and post hoc identification with immunocytochemistry. To visualize disynaptic inhibitory events in SPNs in voltage clamp, we used a CsCl-based internal solution containing the following (in mM): 125 CsCl, 0.1 EGTA, 10 HEPES, 2 MgCl 2 , 4 Na 2 ATP, and 0.4 Na 2 GTP. This solution also contained 0.2% (wt) AlexaFluor-594 or biocytin (Sigma-Aldrich) to verify the identity of SPNs online morphologically. These pipettes had a DC impedance of 3-5 M⍀. Membrane currents and potentials were recorded using an Axoclamp 700B amplifier (Molecular Devices) and digitized at 20 -40 kHz with a CED Micro 1401 Mk II and a PC running signal, version 5 (Cambridge Electronic Design). Optogenetic stimulation consisted of a 5 ms duration blue light pulses (440 nm LED, Mouser Electronics). Sweeps were run at 20 s intervals.
The onset latency was defined as the time between the beginning of the optogenetic stimulation pulse and the onset of the postsynaptic response. The time to peak was determined as the time between the beginning of the stimulation pulse and the peak of the postsynaptic response.
In vivo head-fixed recordings. Six weeks after AAV-Flex-ChR2-GFP (200 nl, University of North Carolina Vector Core) injection into the PPN, animals underwent a second surgery where an implant for head fixation was cemented to the skull around a ϳ1.5 mm ϫ 1.5 mm craniotomy centered on the dorsal striatum (anteroposterior 0.7, mediolateral 1.8). The craniotomy was kept protected using biocompatible silicone (Smooth-On, #0718). Mice were habituated to the head-fixed setup on top of a treadmill. Briefly, mice were exposed to the apparatus and to head fixation in periods of increasing length and with interruptions when mice had free access to food and water in their home cage. Recordings began following habituation of 3-5 consecutive days.
On the day of the recording, a silicone probe (OA1x16 -50-177, Neuronexus) was slowly lowered using a micromanipulator (Scientifica), and the striatum was scanned for single-unit activity. Extracellular signals were digitized and amplified using an Intan chip (Intan Technologies, RHD2216) and recorded as wide band signals using Intan software (RHD2000). When the signal from an individual neuron was acquired and exhibited a signal-to-noise ratio of at least 3:1, a baseline of 3-5 min was recorded. Next, between 60 and 240 optogenetic pulses (20 ms, 0.5 Hz, 3 mW) were delivered through the optic fiber under the control of a TTL generator (Arduino Uno) and triggered by the recording software. After each recording, the probe was moved in a random direction for 200 -400 m (anteroposterior or mediolateral) to avoid multiple recordings of the same neuron. Recorded signals were converted to smr files (Spike2, Cambridge Electronic Design) using a custom MATLAB script. Signals were then bandpass filtered between 500 and 5000 Hz and sorted using the wavemark option in Spike2. Only neurons that showed a confidence interval of Ͼ95% of the action potential (AP) principal component analyses were considered as individual neurons and used for further analyses. The firing rate before (5 s), during (50 ms for interneurons and 100 ms for SPNs), and after (5 s) was determined using a peristimulus time histogram of the average interspike interval (iFr). Percentage changes of Ͼ10% were considered as responding neurons. To calculate changes in activity, the iFr was z scored based on the 5 s before the stimulation. Statistically significant effects were considered changes of ՆϮ2 SD of the z score. The putative nature of recorded neurons was estimated based on previous experiments and was classified using basal firing activity, the coefficient of variation, and AP waveform. Neurons presenting a basal firing rate between 0 and 2 Hz and a half-width AP duration between 1 and 2 ms were considered as putative SPNs (pSPNs); putative FSI (pFSIs) have a shorter half-width AP (Ͻ1 ms) and a higher firing rate (2-16 Hz), whereas putative CINs (pCINs) have a higher firing rate than pSPNs (Ͼ2 Hz) and a wider half-width AP than FSIs.
Motor behavior. Six weeks after AAV-Flex-ChR2-GFP (200 nl, University of North Carolina Vector Core) injection in the PPN, VGLUT2-Cre mice and WT controls were implanted with an optic fiber (200 m, 0.5 NA, Thorlabs) at the level of the dorsal striatum (anteroposterior 0.75, mediolateral 1.75, dorsoventral 2.0), maintained in position with an anchor screw located in the contralateral striatum and all covered in dental cement. Following 5-7 d of recovery, animals were placed in a twocompartment box (total of 80 cm ϫ 40 cm ϫ 40 cm) for 30 min. Each compartment was randomly attributed to an experimental condition: (1) no stimulation or (2) optogenetic stimulation. Animal locomotion and head-body rotation (angular velocity) were monitored using tracking software (Anymaze, Stoelting). All stimuli had a duration of 1 s with an interstimulus interval of 9 s. A laser pulse (10 Hz, 20 ms) was delivered through the cannula under the control of a shutter (SH1, Thorlabs) triggered by TTL pulses generated by the animal tracking interface (Ami1). To account for the possible effect of the sound of the shutter, the nonstimulation condition triggered a similar shutter opening protocol but with the laser turned off. The head-body rotation was obtained by calculating the absolute head-body angle 1 s before the opening of the shutter to 1 s during stimulation. The variation of the head-body angular velocity (Delta) was defined as a change from the angle formed by the head-body axis versus the body-tail axis.
Experimental design and statistics. For the anatomical experiments, a total of 12 mice were used as follows: 3 WT mice for Fluorogold injections, 3 WT mice for AAV-retro-CAG-TdTomato injections, 3 VGLUT2-Cre mice for AAV-retro-Flex-Tdtomato injections, and 3 VGLUT2-Cre mice for AAV-DIO-YFP injections. For ex vivo electrophysiology, a total of 15 VGLUT2-Cre mice were used. A paired t test was used to compare the responses during optogenetic stimulation and after drug perfusion. For in vivo electrophysiology, a total of 6 VGLUT2-Cre mice were used for extracellular recordings. More than 300 neurons were recorded, and 37 were selected for further analysis based on signal-tonoise ratio Ͼ3, AP variation Ͻ1%, and interspike interval Ͼ2 ms. Analysis of the firing rate changes (expressed as percentage change) was defined by comparing the recordings during the laser stimulation (50 or 100 ms) to the recordings immediately before the stimulation (baseline). Firing rates were converted to z scores. One-way or two-way ANOVAs were used to compare the percentage change for all groups and stimulation protocols. For behavioral experiments, a total of 6 VGLUT2-cre and 5 WT mice were used. Parameters of distance traveled, average speed, and head-body/tail-body axes were obtained using Anymaze software, and the effect of the optogenetic stimulation was evaluated by comparing these parameters before each stimulation (baseline) and during the stimulation (1 s). A two-way ANOVA (group ϫ stimulation) was used to compare the percentage change and the z score variation. Data were excluded in those cases where the injection site was out of target, as defined by post hoc histological analysis. For in vivo and ex vivo recordings, cells that were not classified either by their electrophysiological or neurochemical (i.e., immunohistochemistry) properties were not further analyzed. All statistical tests were run using Prism or StataSE.
Results

PPN glutamatergic neurons innervate the striatum
We previously demonstrated in rats, using anterograde and retrograde anatomical tracings, that cholinergic neurons of the PPN innervate the striatum (Dautan et al., 2014) . From the retrogradely labeled neurons, ϳ60%-70% of the PPN neurons were immunopositive for ChAT, suggesting the existence of noncholinergic neurons of the PPN that project to striatum. To determine the proportions of cholinergic and noncholinergic PPN neurons that project to the striatum in the mouse, we first injected a retrograde tracer (Fluorogold) into the striatum of WT mice (C57BL/6, The Jackson Laboratory; n ϭ 3). We found that 64.5% of PPN-labeled neurons were ChAT-negative ( Fig. 1A-D) . Similar results were obtained after the injection of a retrograde AAV that transduced a fluorescent reporter (200 nl, AAV-retro-CAG-TdTomato) into the striatum of WT mice (C57BL/6, The Jackson Laboratory; n ϭ 3). We found that Ͼ60% of retrogradely labeled PPN neurons were ChAT-immunonegative ( Fig. 1E-H ) .
To determine whether striatal-projecting, noncholinergic neurons were glutamatergic, we injected an AAV retro-Flex-tdTomato into the striatum of VGLUT2-Cre mice. We detected tdTomatolabeled neurons in the PPN, as defined by the ChAT staining outline ( Fig. 1I-N ) , indicating that PPN glutamatergic neurons innervate the striatum. Furthermore, we detected retrogradely labeled PPN neurons both ipsilateral and contralateral to the striatal injection, suggesting that these projections are bilateral (data not shown). Only ϳ4% of PPN VGLUT2-positive neurons that project to the striatum were also ChAT-positive, in agreement with a previous report (Wang and Morales, 2009 ; and data not shown). Next, we examined the distribution of PPN gluta-matergic axons in the striatum by transducing them with a fluorescent reporter injected into the PPN (AAV2-DIO-YFP, 50 nl, VGLUT2-Cre mice, n ϭ 3; Fig. 2A ). We detected the presence of YFP-positive axons across large areas of the both the dorsal and ventral striatum (Fig. 2C-E) . Within the striatum, we observed a dorsoventral as well as anteroposterior gradient of these projections where the dorsal part (close to the corpus callosum) is more innervated than the ventral part, and the anterior part is more densely innervated than the posterior part. Finally, conditional labeling of the presynaptic protein synaptophysin in PPN gluta- matergic axons (AAV-DIO-GFP-2A-mRuby-synaptophysin in VGLUT2-Cre mice) revealed the presence of synaptophysinpositive axon terminals throughout the entire extent of the striatum ( Fig. 2G-J ) . These results demonstrate the existence of a glutamatergic projection originated in the PPN that forms synaptic contacts across large extents of the striatum.
PPN glutamatergic neurons do not directly innervate SPNs
To identify the striatal synaptic target(s) of PPN glutamatergic neurons, a floxed ChR2 virus (200 nl; AAV2-DIO-ChR2, n ϭ 15 mice) was injected into the PPN of VGLUT2-Cre mice and whole-cell recordings were obtained from striatal neurons in acute brain slices. SPNs were identified in brain slices based on their well-established intrinsic electrophysiological properties (Fig. 3A) and post hoc after streptavidin labeling of their densely spinous dendritic arborization. Surprisingly, essentially none of the recorded SPNs in the transduction field exhibited the expected monosynaptic excitatory responses to optogenetic stimulation of PPN glutamatergic striatal terminals (V h ϭ Ϫ70 mV; n ϭ 45 of 46 not responding; 97.8% Fig. 3 B, C) , and the single SPN that responded exhibited only a very small inward current (ϳ4pA). Those results demonstrate that PPN glutamatergic neurons do not monosynaptically innervate SPNs.
We then examined responses of SPNs to activation of PPN glutamatergic inputs using an internal solution containing 125 mM CsCl to enhance detection of GABAergic IPSCs. In contrast to the results described above, under these conditions, we observed that, in 48.38% of the recorded SPNs, optogenetic stimulation of PPN glutamatergic inputs elicited IPSCs (n ϭ 15 of 31; 15.16 Ϯ 2.661 pA; Fig. 3D-M ) . These IPSCs were mediated by GABA A receptors as they were blocked by bicuculline (10 M, n ϭ 6; two-tailed paired t test, p ϭ 0.0172; time constant: 8.515 Ϯ 1.142 ms, n ϭ 14; Fig. 3D -M ) and exhibited unusually long latencies (8.459 Ϯ 0.698 ms; Fig. 3 H, I; n ϭ 15 ) implying mediation by polysynaptic pathways. The IPSCs were also blocked by bath application of AMPA/NMDA glutamate receptor antagonists ( Fig. 3 L, M; n ϭ 6) , which confirmed the polysynaptic nature of the response. These results suggest that activation of PPN glutamatergic axons in the striatum induced feedforward inhibition of SPNs.
PPN glutamatergic neurons innervate striatal cholinergic and fast-spiking interneurons
We recorded from a number of interneuron types, including large numbers of CINs and FSIs and smaller numbers of LTS and TH interneurons . CINs were identified in slices by their large cell body size, their unique intrinsic properties (e.g., spontaneous tonic firing, long duration AP, I h sag current; Fig. 4A ), and post hoc following immunostaining for ChAT (Fig.  4M ) . In contrast to SPNs, the vast majority of CINs responded to the optogenetic stimulation of PPN glutamatergic axons (n ϭ 26 of 28; 92.9%; Fig. 4B ). The stimulation (5 pulses, 20 Hz) evoked large EPSPs and AP firing in CINs both in cell-attached and in whole-cell current clamp (Fig. 4C,D) . Whole-cell voltage-clamp recordings (V h ϭ Ϫ70 mV) revealed that the EPSC is relatively large (103.48 Ϯ 15.23 pA; n ϭ 19) and exhibits strong short-term depression (p1: 89.33 Ϯ 17.59; p2: 27.74 Ϯ 8.28; p3: 26.2 Ϯ 6.76; p4: 23.43 Ϯ 6.53; p5: 22 .82 Ϯ 5.71 pA; n ϭ 19; Fig. 4E-L) . We also measured changes in the amplitude of a test EPSC produced by a preceding, conditioning terminal volley and calculated the paired-pulse ratio (PPR). We used a range of different interstimulus intervals (50, 100, 200, 500, and 1000 ms) . Our results confirm the depressing nature of the PPN glutamatergic synapses onto CINs, which persist even at longer interstimulus intervals (results are expressed as a ratio of the first EPSC, PPR 50ms : 0.41 Ϯ 0.067; PPR 100ms : 0.47 Ϯ 0.068; PPR 200ms : 0.48 Ϯ 0.068; PPR 500ms : 0.57 Ϯ 0.069; PPR 1000ms : 0.62 Ϯ 0.047; Fig. 4L ). Consistent with a monosynaptic activation of CINs by PPN glutamatergic terminals, the excitatory responses exhibit a short-onset latency (5.52 Ϯ 0.23 ms; Fig. 4G ) and are blocked by AMPA/NMDA glutamate receptor antagonists (CNQX and APV, respectively; 10 M; 94.23 Ϯ 2.01% reduction in EPSC size; paired t test; p ϭ 0.0051; n ϭ 7; Fig. 4 I, J ). While this latency is longer compared with some optogenetic studies (Cruikshank et al., 2007; Brill et al., 2016) , it is consistent with the latencies of monosynaptic activation by extrinsic inputs previously reported (Saunders et al., 2016; Assous et al., 2017; Klug et al., 2018) .
Next, we measured the response of FSIs to optogenetic stimulation of PPN glutamatergic neurons. FSIs were identified based on their intrinsic electrophysiological properties (low input resistance, high rheobase current, fast AP firing at depolarized current steps; Fig. 5A ) and the expression of parvalbumin (Fig. 5J ). Similar to CINs, the vast majority of FSIs (n ϭ 7 of 9; 77.8%; Fig. 5B ) responded to the stimulation with EPSCs (n ϭ 6; 134.5 Ϯ 30.9 pA; Fig. 5C ,E) that exhibited a strong short-term depression (5 pulses, 20 Hz; p1: 155.7 Ϯ 29.02; p2: 60.16 Ϯ 15.76; p3: 80.67 Ϯ 27.46; p4: 58.2 Ϯ 21.66; p5: 72.13 Ϯ 22.4 pA; n ϭ 4; Fig. 5I ). Consistent with a monosynaptic innervation of striatal FSIs by PPN glutamatergic neurons, EPSCs/EPSPs exhibited a shortonset latency (5.49 Ϯ 0.26 ms; Fig. 5F-H ) and were blocked by glutamate receptor antagonists (CNQX and APV 10 M; n ϭ 5; 93.95 Ϯ 0.58% reduction; paired t test; p ϭ 0.0006; Fig. 5C,D) .
Additionally, we recorded the light-evoked response of a limited number of two other striatal GABAergic interneuron populations, the TH expressing GABAergic interneurons and NPY-expressing low-threshold spike (LTS) interneurons that were identified based on their intrinsic electrophysiological properties (Kawaguchi, 1993; Ibáñez-Sandoval et al., 2010) . Both interneurons showed suprathreshold excitatory responses to the optogenetic stimulation similar to those observed in CINs and FSIs (data not shown). Together, these results show that PPN glutamatergic neurons selectively innervate every subtype of striatal interneuron tested thus far.
PPN glutamatergic neurons modulate striatal output
To identify the impact of excitatory transmission arising in the PPN on striatal function, we tested the effects of optogenetic stimulation of PPN glutamatergic axons on striatal neurons in vivo. First, to determine whether PPN-driven feedforward inhibitory mechanisms occurred in vivo, we recorded the electrophysiological responses of striatal neurons following the local optogenetic stimulation of PPN glutamatergic axons in awake, head-fixed mice using multicontact electrodes (Fig. 6A) . We recorded extracellularly 37 single units that were clustered as pSPNs, pFSIs, or pCINs, based on their basal firing rate, AP duration, and coefficient of variation (see Materials and Methods; n ϭ 6 mice). Stimulation of PPN glutamatergic axons produced a significant decrease in the firing rate of pSPNs (n ϭ 11 of 17; basal firing rate: 0.61 Ϯ 0.089 Hz; firing rate during stimulation: 0.47 Ϯ 0.074 Hz) (n ϭ 17; paired t test, t (33) ϭ Ϫ8.40, p ϭ 0.000001), whose latency (71.714 Ϯ 5.53 ms) suggested the involvement of polysynaptic pathways (Fig. 6 B, E-G) . Consistent with the results obtained in ex vivo whole-cell recordings, we detected an increase in the firing rate of pFSIs (n ϭ 6 of 6; 100%; basal: 5.96 Ϯ 0.91 Hz, stimulation: 22.54 Ϯ 5.14 Hz; paired t test, t (11) ϭ 3.72, p ϭ 0.0034) and pCINs (n ϭ 11 of 14; 78.6%; basal: 5.64 Ϯ 0.72 Hz, stimulation: 8.8 Ϯ 1.19; Hz paired t test, t (27) ϭ 8.0091, p ϭ 0.00001), both with a shorter latency than SPNs (9.83 Ϯ 0.6 ms and 9.07 Ϯ 0.22 ms, respectively) and consistent with monosynaptic activation (Fig. 6C-G) . Additionally, we also detected longlatency increases in the firing rate of both pFSIs and pCINs, which we attributed to the involvement of polysynaptic pathways, but they were not further analyzed (Fig. 6E) .
Next, to determine the impact of PPN-driven, feedforward inhibition of SPNs on striatal functions, we tested the motor effects of the unilateral stimulation of PPN glutamatergic axons in freely moving mice. For this purpose, PPN neurons in VGLUT2-Cre mice were transduced with ChR2 as before, and an optic fiber was chronically implanted into the right dorsal striatum (n ϭ 6). A control group consisted of WT mice receiving the same injections and implantations (n ϭ 5). Optogenetic stimulation (1 s every 9 s, 10 Hz, 20 ms pulses, 3 mW; Fig. 7A-C) had no significant effect on the distance traveled (two-way ANOVA: group effect: F (1,18) ϭ 0.81, p ϭ 0.3813; Fig. 7D -F ) but produced ipsiversive head rotations, an effect that has recently been associated with the optogenetic inhibition of the direct and indirect striatal projection pathways (Tecuapetla et al., 2014) (comparison between the angles formed by the head-body axis with the body-tail axis; angle: 8.91 Ϯ 14.83°before vs 57.97 Ϯ 20.59°after PPN axon stimulation; in the control group: Ϫ6.26 Ϯ 3.95°before vs Ϫ7.94 Ϯ 2.54°after stimulation; two-way ANOVA: stimulation ϫ group, stimulation effect, F (1,21) ϭ 2.37, p ϭ 0.1399; group effect, F (1,21) ϭ 1.13, p ϭ 0.3004; interaction effect, F (2,21) ϭ 3.74, p ϭ 0.0426; Bonferroni post hoc test: PPNstim vs PPNnostim ϭ 0.0096; ctrlstim vs ctrlnostim ϭ 1.0; Figure 7G -J ). These results suggest that, in the behaving mouse, activation of PPN glutamatergic axons in the striatum is able to inhibit SPNs and consequently reduce the striatal output.
Discussion
Our results in this study demonstrate the existence of an excitatory glutamatergic projection that originates in the PPN and modulates striatal neuronal activity. Using ex vivo recordings, we show that this projection selectively targets multiple subtypes of striatal interneurons and generates feedforward inhibition in SPNs. Using in vivo extracellular recordings, we demonstrate that striatal interneurons are activated following the stimulation of PPN glutamatergic axons, and SPNs show a long-latency decrease in firing rate. Last, in behaving animals, we show that unilateral optogenetic activation of this pathway induces ipsilateral head rotations, consistent with inhibition of SPNs. Our results then reveal a unique mechanism by which midbrain glutamatergic projections selectively recruit striatal interneurons resulting in suppression of striatal output.
One of the critical findings of this study is the demonstration of a novel source of feedforward inhibition to SPNs originating in glutamatergic neurons of the PPN. Interneuron-mediated feedforward inhibition has been shown to be a key mechanism for regulating striatal activity. In structures, such as the cortex or hippocampus, local inhibition is mediated by interneurons via two types of regulatory mechanisms: feedback and feedforward inhibition (Isaacson and Scanziani, 2011) . Both forms of inhibition are involved in regulating spike timing and network gain, controlling temporal integration and expanding the dynamic range of responses (Gabernet et al., 2005; Cruikshank et al., 2007; Pouille et al., 2009; Atallah et al., 2012; Lee et al., 2012; Moyer et al., 2014; Owen et al., 2018) . In contrast, in the striatum, interneurons regulate spike timing of SPNs only through feedforward inhibition due to the GABAergic nature of the principal cells (Tepper et al., 2008) . Here, following optogenetic activation of PPN glutamatergic axons, we identified excitatory responses in CINs and FSIs as well as in a limited number of TH and LTS GABAergic interneurons, thus suggesting that the PPN is able to activate most, if not all, striatal interneurons. An alternative scenario is possible in which there is selective innervation of interneuron subtypes, such as those described for the thalamus (NPY-expressing NGF and LTS interneurons) (Assous et al., 2017) ; however, there are no data to support this idea. Because FSIs, TH, and LTS interneurons are GABAergic and directly innervate SPNs (Koó s and Tepper, 1999; Gittis et al., 2010; Ibáñez-Sandoval et al., 2010 Straub et al., 2016) , and because CINs induce potent disynaptic inhibition of SPNs through activation of several populations of striatal GABAergic interneurons (English et al., 2011; Nelson et al., 2014; Faust et al., 2016) , our results thus reveal the existence of a source of excitation arising in the midbrain that is selective for interneurons and induces a longlatency polysynaptic inhibition of SPNs without concurrent excitation. The question of a selective feedforward inhibition of either direct-or indirect-pathway SPNs was not tested. However, the interneurons targeted by the PPN glutamatergic neurons (FSIs, LTS, TH as well as the GABAergic interneurons responsible for the disynaptic inhibition of SPNs after CINs activation) have been shown to target both direct and indirect pathway SPNs (Gittis et al., 2010; Ibáñez-Sandoval et al., 2010 English et al., 2011; Xenias et al., 2015) , suggesting that both SPNs populations are subject to this feedforward inhibition pathway originating from the PPN. Interestingly, striatal interneurons are also interconnected to each other in a highly specific manner; and therefore, disinhibitory mechanisms may also play a role in this midbrain modulation (e.g., TH interneuron-mediated inhibition of LTS interneurons) (Assous et al., 2017; Assous and Tepper, 2019) .
The glutamatergic inputs to striatal CINs have been shown to originate mostly from the intralaminar thalamic nuclei (predominantly expressing VGLUT2) and, more moderately, from different areas of the cortex (predominantly expressing VGLUT1). Thalamic inputs to striatal CINs have been shown to modulate goal-directed learning following changes in action-outcome contingencies (Bradfield et al., 2013) , and are also suggested to participate in the typical pause-burst response of CINs following the presentation of a salient stimulus (Matsumoto et al., 2001 ; Goldberg and Reynolds, 2011; Schulz and Reynolds, 2013). Electro- physiologically, this multiphasic pattern of firing of CINs has been attributed, in part, to the facilitating nature of the thalamostriatal synapses onto CINs (Ding et al., 2010; Doig et al., 2014) . Here, we show that the amplitude and the suprathreshold nature of the responses to PPN glutamatergic axons in the striatum are comparable with those originating in the thalamus (Ding et al., 2010; Assous et al., 2017;  for review, see Smith et al., 2004 Smith et al., , 2014 . Furthermore, the nature of the response of striatal interneurons (FSIs and CINs) to the PPN optogenetic stimulation is also multiphasic, consisting of a short latency increase (most likely monosynaptic) and a second increase in firing rate after a longer delay. This late response likely involves polysynaptic extrastriatal relays, such as the thalamus or the cortex, structures that are also innervated by the PPN glutamatergic axons and provide innervation to striatal neurons. However, the short-term plasticity of the PPN to CINs synapses is strongly depressing and contrasts with that mediated by the synapses originating from the thalamus, thus suggesting a different effect, and perhaps a different role, of thalamic and PPN glutamatergic axons on CINs.
In this study, we also reveal that striatal-projecting midbrain PPN glutamatergic neurons are embedded in a region that has been functionally defined as the mesencephalic locomotor region (for review, see Mena-Segovia and Bolam, 2017) . Together with the cuneiform nucleus, activation of mesencephalic locomotor region excitatory pathways has been suggested to modulate locomotor speed and gait (Roseberry et al., 2016; Caggiano et al., 2018) . Recent studies (Josset et al., 2018) , including our own unpublished data, however, have reported that the optogenetic activation of PPN glutamatergic neurons, rather than inducing an increase in motor activity, induces a reduction in movement, suggesting that the PPN recruits spinal circuits to halt locomotion (Takakusaki et al., 2016) . The present ex vivo and in vivo experiments show that activation of PPN afferents induces inhibition of SPNs and therefore is capable of inhibiting the striatal output. Consistent with these findings, unilateral activation of PPN axons in the striatum in freely moving mice induced ipsilateral head rotations, in line with the optogenetic silencing of both populations of SPNs (Tecuapetla et al., 2014) . In other words, excitatory afferents from the PPN/mesencephalic locomotor region are capable of suppressing striatal output by means of a feedforward inhibition mechanism. Together with the recently described functions of movement inhibition, our results situate the PPN as a key modulator of striatal activity. Furthermore, our findings reveal the PPN as the only known excitatory input capable of driving striatal inhibition without concurrent excitation of SPNs.
